Cravatex (BSE 509472)₹371.25+3.07%Trading & Distributors
In the Sep 2026 quarter (consolidated), Cravatex reported sales of ₹53.38 Cr, up 3.8% from Sep 2025, and net profit of ₹4.61 Cr, down 11.5% year on year. For the year to Mar 2026, sales were ₹151 Cr and net profit ₹6.98 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 37.87 | 50.60 | 25.75 | 54.93 | 32.41 | 60.42 | 23.11 | 51.42 | 36.73 | 39.47 | 32.19 | 53.38 |
| Expenses | 41.83 | 52.73 | 28.21 | 53.17 | 34.42 | 60.17 | 29.34 | 48.83 | 39.37 | 40.25 | 35.59 | 50.56 |
| Operating Profit | −3.80 | −1.89 | −2.34 | 2.02 | −1.88 | 0.52 | −6.13 | 2.76 | −2.45 | −0.60 | −3.28 | 3.07 |
| OPM % | −10.0% | −3.7% | −9.0% | 3.7% | −5.8% | 0.8% | −26.4% | 5.4% | −6.6% | −1.5% | −10.2% | 5.7% |
| Other Income | 5.84 | 2.69 | 3.49 | 2.15 | 2.25 | 2.10 | 5.22 | 3.81 | 4.53 | 3.31 | 4.41 | 3.38 |
| Interest | 0.12 | 0.10 | 0.10 | 0.10 | 0.10 | 0.08 | 0.08 | 0.08 | 0.08 | 0.08 | 0.07 | 0.07 |
| Depreciation | 0.48 | 0.40 | 0.35 | 0.35 | 0.41 | 0.41 | 0.39 | 0.39 | 0.39 | 0.38 | 0.39 | 0.39 |
| Profit before tax | 1.42 | 0.31 | 0.71 | 3.71 | −0.15 | 2.12 | −1.38 | 6.09 | 1.62 | 2.26 | 0.68 | 5.98 |
| Tax % | 43.9% | −70.1% | 29.9% | 28.3% | −278.7% | 31.7% | 0.7% | 14.3% | 16.7% | 28.4% | 34.3% | 22.6% |
| Net Profit | 0.78 | 0.49 | 0.47 | 2.64 | 0.24 | 1.43 | −1.36 | 5.21 | 1.34 | 1.59 | 0.43 | 4.61 |
| EPS (Rs) | 3.05 | 1.92 | 1.85 | 10.22 | 0.96 | 5.55 | −5.28 | 20.13 | 5.20 | 6.17 | 1.69 | 17.83 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 255 | 266 | 356 | 717 | 863 | 531 | 593 | 504 | 203 | 174 | 151 | 162 |
| Expenses | 250 | 272 | 362 | 696 | 846 | 545 | 594 | 535 | 211 | 175 | 158 | 166 |
| Operating Profit | 6.02 | −5.01 | −6.03 | 24.07 | 21.08 | −11.05 | 2.01 | −30.13 | −8.03 | −2.01 | −6.02 | −3.26 |
| OPM % | 2.3% | −1.7% | −1.6% | 3.4% | 2.5% | −2.1% | 0.4% | −6.0% | −3.8% | −1.0% | −4.2% | −2.0% |
| Other Income | 3.01 | 4.01 | 4.01 | 4.01 | 5.01 | 13.03 | 10.02 | 118 | 16.04 | 10.02 | 17.03 | 15.63 |
| Interest | 12.96 | 10.96 | 4.99 | 5.98 | 13.95 | 14.96 | 13.96 | 13.96 | 0.00 | 0.00 | 0.00 | 0.30 |
| Depreciation | 3.01 | 3.01 | 6.01 | 5.99 | 15.02 | 17.02 | 16.01 | 16.01 | 2.01 | 1.01 | 2.01 | 1.55 |
| Profit before tax | −7.01 | −15.02 | −12.03 | 17.04 | −2.01 | −30.04 | −19.03 | 58.10 | 6.01 | 6.01 | 9.02 | 10.54 |
| Tax % | 8.0% | −9.1% | 2.0% | 36.9% | 94.9% | 3.0% | 7.0% | −1.0% | 21.9% | 23.9% | 20.9% | — |
| Exceptional items | 0.00 | 0.00 | 0.44 | 0.11 | 0.00 | −0.46 | 0.15 | 104 | 0.03 | 0.02 | 0.07 | — |
| Net Profit | −7.99 | −13.98 | −11.97 | 10.98 | −4.99 | −30.95 | −19.96 | 58.91 | 4.99 | 4.99 | 6.98 | 7.97 |
| EPS (Rs) | −30.54 | −53.55 | −47.61 | 41.10 | −18.17 | −118.18 | −76.76 | 227.34 | 18.65 | 18.64 | 26.24 | 30.89 |
| Dividend payout % | 0.0% | 0.0% | −2.0% | 5.0% | −16.0% | −3.0% | −4.0% | 1.0% | 16.0% | 67.0% | 49.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 | 2.99 |
| Reserves | 40.84 | 32.87 | 18.93 | 6.97 | 16.95 | −3.98 | −30.90 | −51.82 | 89.70 | 95.66 | 104 | 117 |
| Borrowings | 65.86 | 71.75 | 135 | 105 | 117 | 201 | 155 | 166 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 53.74 | 66.72 | 62.70 | 93.71 | 162 | 240 | 258 | 246 | 43.88 | 26.00 | 33.90 | 26.95 |
| Total Liabilities | 163 | 174 | 219 | 207 | 298 | 440 | 384 | 364 | 137 | 125 | 140 | 146 |
| Fixed Assets | 28.90 | 27.91 | 52.85 | 47.88 | 47.83 | 91.79 | 75.80 | 61.85 | 7.98 | 8.97 | 8.97 | 7.98 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 6.02 | 1.01 | 25.08 | 15.05 | 5.02 | 5.02 | 8.03 | 16.04 | 19.04 |
| Other Assets | 135 | 146 | 166 | 155 | 249 | 323 | 293 | 297 | 124 | 108 | 115 | 119 |
| Inventories | 48.90 | 55.92 | 41.95 | 35.95 | 83.91 | 81.79 | 84.92 | 93.83 | 28.96 | 10.99 | 10.97 | 22.96 |
| Trade receivables | 72.99 | 74.02 | 60.95 | 103 | 150 | 169 | 143 | 133 | 25.99 | 13.99 | 23.99 | 16.01 |
| Cash & equivalents | 3.99 | 7.97 | 56.82 | 6.98 | 4.98 | 48.84 | 35.87 | 37.91 | 55.85 | 75.79 | 74.81 | 76.70 |
| Total Assets | 163 | 174 | 219 | 207 | 298 | 440 | 384 | 364 | 137 | 125 | 140 | 146 |
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 34.99 | −12.99 | −5.01 | 32.01 | −3.99 | −8.01 | 144 | 18.98 | 2.99 | 0.99 |
| Cash from investing activity | −24.01 | −4.01 | 3.01 | −37.01 | 21.01 | 14.01 | 42.03 | −0.99 | −1.01 | 2.99 |
| Cash from financing activity | 37.91 | −33.91 | 0.00 | 36.88 | −20.93 | −3.99 | −167 | 0.00 | −0.99 | −2.99 |
| Net cash flow | 49.87 | −50.81 | −1.99 | 31.88 | −3.99 | 2.99 | 17.94 | 16.96 | 1.99 | 0.99 |
| Capex | 21.92 | 0.59 | 5.79 | 8.09 | 2.69 | 1.72 | 0.00 | 1.02 | 1.77 | 0.41 |
| Free cash flow | 13.01 | −13.03 | −10.02 | 24.04 | −6.02 | −9.02 | 182 | 18.03 | 1.01 | 1.01 |
| CFO / OP % | −779.0% | 188.0% | −10.0% | 163.0% | 25.0% | −300.0% | −485.0% | −274.0% | −245.0% | −48.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 116 | 107 | 85 | 107 | 77 | 73 | 99 | 83 | 20 | 26 | 51 | 41 |
| Inventory days | 123 | 123 | 83 | 52 | 59 | 48 | 84 | 83 | 28 | 27 | 39 | 110 |
| Days payable | 66 | 71 | 65 | 89 | 16 | 25 | 23 | 36 | 21 | 25 | 43 | 39 |
| Cash conversion cycle | 172 | 158 | 101 | 69 | 119 | 94 | 159 | 129 | 26 | 27 | 46 | 110 |
| Working capital days | 42 | 20 | −4 | 40 | 27 | 10 | 24 | 29 | 16 | 15 | 19 | 43 |
| ROCE % | 12.0% | 5.0% | −3.0% | −6.0% | 18.0% | 6.0% | −6.0% | −2.0% | −24.0% | 7.0% | 7.0% | 8.0% |
For the Sep 2026 quarter, Cravatex reported sales of ₹53.38 Cr, up 3.8% year on year and net profit of ₹4.61 Cr, down 11.5% year on year. The operating margin was 5.7%.
Cravatex's sales for the year to Mar 2026 were ₹151 Cr; over the last twelve months they were ₹162 Cr.
Net profit for the year to Mar 2026 was ₹6.98 Cr, and ₹7.97 Cr over the last twelve months. Earnings per share over the same trailing period were ₹30.89.
Cravatex reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹76.70 Cr.
Cash from operations was ₹0.99 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹1.01 Cr.